1-(6-Ethoxypyrimidin-4-yl)piperidine-3-carboxylic acid
95%
- Product Code: 131532
CAS:
1353984-32-3
| Molecular Weight: | 251.28 g./mol | Molecular Formula: | C₁₂H₁₇N₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD21098539 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Commonly employed in research settings to design drugs that modulate signaling pathways involved in tumor growth and inflammation. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿8,060.00 |
+
-
|
| 250mg | 10-20 days | ฿13,700.00 |
+
-
|
1-(6-Ethoxypyrimidin-4-yl)piperidine-3-carboxylic acid
Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Commonly employed in research settings to design drugs that modulate signaling pathways involved in tumor growth and inflammation. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :